Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03860220
PHASE4

The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

Sponsor: Hyo-Soo Kim

View on ClinicalTrials.gov

Summary

The goal of this study was to assess the efficacy and safety of FDC therapy with triple therapy of Telmisartan 40 mg/Amlodipine 5 mg/Rosuvastatin 10mg in Korean patients with both hypertension and dyslipidemia.

Official title: A Multi-center, Randomized, Parallel Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients With Dyslipidemia and Hypertension

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

252

Start Date

2019-04-25

Completion Date

2023-09-07

Last Updated

2026-04-27

Healthy Volunteers

No

Interventions

DRUG

NEWSTATIN TS

Wash out/run in period with Amlodipine 5mg for 6 weeks and then treatment with triple therapy (Newstatin TS 40/5/10mg) ; 1 tab qd for 8 weeks

DRUG

CADUET

Wash out/run in period with Amlodipine 5mg for 6 weeks and then treatment with dual therapy (Caduet 5/10mg) ; 1 tab qd for 8 weeks

Locations (9)

Kangwon National University Hospital

Chuncheon, Gangwon-do, South Korea

Korea University Ansan Hospital

Ansan, Gyeonggi-do, South Korea

Hallym University Sacred Heart Hospital

Anyang-si, Gyeonggi-do, South Korea

CHA Bundang Medical Center, CHA University

Seongnam-si, Gyeonggi-do, South Korea

Yeungnam University Hospital

Daegu, South Korea

Severance Hospital, Yonsei University Health System

Seoul, South Korea

Hallym University Kangnam Sacred Heart Hospital

Seoul, South Korea

Kyung Hee University Hospital at Gangdong

Seoul, South Korea

Yonsei University Wonju Severance Christian Hospital

Wŏnju, South Korea